Evolent Health (NYSE:EVH) Beats Q3 Sales Expectations, Stock Jumps 14.8% [Yahoo! Finance]
Evolent Health, Inc Class A (EVH)
Last evolent health, inc class a earnings: 2/25 04:02 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.evolenthealth.com
Company Research
Source: Yahoo! Finance
On the other hand, next quarter's revenue guidance of $467 million was less impressive, coming in 1.2% below analysts' estimates. Its non-GAAP profit of $0.05 per share was 52.5% below analysts' consensus estimates. Is now the time to buy Evolent Health? Find out in our full research report Evolent Health (EVH) Q3 CY2025 Highlights: Revenue: $479.5 million vs analyst estimates of $467.3 million (22.8% year-on-year decline, 2.6% beat) Adjusted EPS: $0.05 vs analyst expectations of $0.11 (52.5% miss) Adjusted EBITDA: $38.96 million vs analyst estimates of $37.67 million (8.1% margin, 3.4% beat) Revenue Guidance for Q4 CY2025 is $467 million at the midpoint, below analyst estimates of $472.9 million EBITDA guidance for the full year is $149 million at the midpoint, below analyst estimates of $151.7 million Operating Margin: 0.2%, up from -2.6% in the same quarter last year Free Cash Flow Margin: 1.4%, similar to the same quarter last year Sales Volumes rose 5.2% year
Show less
Read more
Impact Snapshot
Event Time:
EVH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVH alerts
High impacting Evolent Health, Inc Class A news events
Weekly update
A roundup of the hottest topics
EVH
News
- Evolent Health (NYSE:EVH) was given a new $6.00 price target on by analysts at Piper Sandler.MarketBeat
- Evolent Health (NYSE:EVH) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $11.50 to $9.50. They now have a "buy" rating on the stock.MarketBeat
- Evolent Health, American Oncology Network Partner to Streamline Cancer Care [Yahoo! Finance]Yahoo! Finance
- Evolent Health (NYSE:EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $13.00 to $7.00. They now have an "overweight" rating on the stock.MarketBeat
EVH
Earnings
- 11/6/25 - Beat
EVH
Sec Filings
- 12/2/25 - Form 8-K
- 11/19/25 - Form 4
- 11/14/25 - Form SCHEDULE
- EVH's page on the SEC website